Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of NutriLife

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3945/jn.112.163931PMID 23077197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trans-10, cis-12-conjugated linoleic acid modulates NF-κB activation and TNF-α production in porcine peripheral blood mononuclear cells via a PPARγ-dependent pathway.

  2011cited by this paper
• Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases

  2011cited by this paper
• New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease

  2011cited by this paper
• Importance and regulation of the colonic mucus barrier in a mouse model of colitis.

  2011cited by this paper
• Inflammatory bowel disease.

  2011cited by this paper
• Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.

  2010cited by this paper
• Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.

  2010cited by this paper
• Conjugated linoleic acid and inflammatory cell signalling.

  2010cited by this paper
• Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.

  2010cited by this paper
• Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease

  2010cited by this paper
• Intestinal barrier dysfunction in inflammatory bowel diseases.

  2009cited by this paper
• Dietary fatty acids and the immune system.

  2009cited by this paper
• Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.

  2008cited by this paper
• Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.

  2008cited by this paper
• Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells.

  2007cited by this paper
• Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat.

  2007cited by this paper
• Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans.

  2007cited by this paper
• Dietary fatty acids and the immune system

  2007cited by this paper
• PPARgamma physiology and pathology in gastrointestinal epithelial cells.

  2007cited by this paper
• Peroxisome proliferator-activated receptor γ (PPARγ) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells

  2007cited by this paper
• Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans

  2007cited by this paper
• Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

  2006cited by this paper
• PPARgamma as a new therapeutic target in inflammatory bowel diseases.

  2006cited by this paper
• Physiological properties of conjugated linoleic acid and implications for human health.

  2006cited by this paper
• Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators*

  2006cited by this paper
• CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.

  2006cited by this paper
• PPARγ as a new therapeutic target in inflammatory bowel diseases

  2006cited by this paper
• Interferon‐gamma is causatively involved in experimental inflammatory bowel disease in mice

  2006cited by this paper
• Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ

  2005cited by this paper
• Analysis of intestinal haem‐oxygenase‐1 (HO‐1) in clinical and experimental colitis

  2005cited by this paper
• the Peroxisome Proliferator‐Activated Receptor &ggr; Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice With Interleukin 10 Deficiency

  2005cited by this paper
• Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease

  2004cited by this paper
• PPARgamma mediates NSAIDs-induced upregulation of TFF2 expression in gastric epithelial cells.

  2004cited by this paper
• Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.

  2004influential reference
• Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment.

  2004cited by this paper
• PPARγ mediates NSAIDs‐induced upregulation of TFF2 expression in gastric epithelial cells

  2004cited by this paper
• Trefoil factors: initiators of mucosal healing

  2003cited by this paper
• Trefoil factors: initiators of mucosal healing

  2003cited by this paper
• A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.

  2003cited by this paper
• The current future understanding of inflammatory bowel disease.

  2002cited by this paper
• Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid.

  2002cited by this paper
• Colonic anti-inflammatory mechanisms of conjugated linoleic acid.

  2002cited by this paper
• Inflammatory bowel disease.

  2002cited by this paper
• Peroxisome Proliferator-Activated Receptor Gamma Agonist Ligands Stimulate a Th2 Cytokine Response and Prevent Acute Colitis

  2002cited by this paper
• Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.

  2002cited by this paper
• Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanism

  2002cited by this paper
• Aspirin promotes TFF2 gene activation in human gastric cancer cell lines

  2001cited by this paper
• Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.

  2001cited by this paper
• Mucins and inflammatory bowel disease

  2000cited by this paper
• Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-&agr; Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase

  2000cited by this paper
• Fatty acids and immune responses--a new perspective in searching for clues to mechanism.

  2000cited by this paper
• Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.

  2000cited by this paper
• The PPAR activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male CD-1 mice.

  1999cited by this paper
• A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

  1999cited by this paper
• Differentiation and reversal of malignant changes in colon cancer through PPARγ

  1998cited by this paper
• Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids.

  1998cited by this paper
• Mucins and inflammatory bowel disease.

  1997cited by this paper
• Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor

  1996cited by this paper
• Peroxisome proliferator-activated receptors: finding the orphan a home

  1994cited by this paper
• A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

  1990cited by this paper
• The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

  1968cited by this paper

• Exploiting conjugated linoleic acid for health: a recent update.

  2024cites this paper
• Conjugated linoleic acid ameliorates necrotizing enterocolitis by suppressing inflammatory responses and maintaining intestinal barrier integrity via the PPARγ/NFκB signaling pathway

  2024cites this paper
• An Exopolysaccharide from Genistein-Stimulated Monascus Purpureus: Structural Characterization and Protective Effects against DSS-Induced Intestinal Barrier Injury Associated with the Gut Microbiota-Modulated Short-Chain Fatty Acid-TLR4/MAPK/NF-κB Cascade Response.

  2024cites this paper
• Levels of lipid-derived gut microbial metabolites differ among plant matrices in an in vitro model of colon fermentation.

  2024cites this paper
• Conjugated linoleic acid (CLA) as a functional food: Is it beneficial or not?

  2023cites this paper
• Diet-Induced Host–Microbe Interactions: Personalized Diet Strategies for Improving Inflammatory Bowel Disease

  2022cites this paper
• Conjugated linoleic acid modifies transcriptional cytokine profile and induces early specific secretory IgA response in Giardia lamblia infected mice

  2022cites this paper
• Insights into gut microbiota metabolism of dietary lipids: the case of linoleic acid.

  2022cites this paper
• Bifidobacterium pseudocatenulatum Ameliorates DSS-Induced Colitis by Maintaining Intestinal Mechanical Barrier, Blocking Proinflammatory Cytokines, Inhibiting TLR4/NF-κB Signaling, and Altering Gut Microbiota.

  2021cites this paper
• Bifidobacterium longum Ameliorates Dextran Sulfate Sodium-Induced Colitis by Producing Conjugated Linoleic Acid, Protecting Intestinal Mechanical Barrier, Restoring Unbalanced Gut Microbiota, and Regulating the Toll-Like Receptor-4/Nuclear Factor-κB Signaling Pathway.

  2021cites this paper
• Melatonin Attenuates Dextran Sodium Sulfate Induced Colitis in Obese Mice

  2021cites this paper
• Influences of dietary oils and fats, and the accompanied minor content of components on the gut microbiota and gut inflammation: A review

  2021cites this paper
• Linoleate Isomerase Complex Contributes to Metabolism and Remission of DSS-Induced Colitis in Mice of Lactobacillus plantarum ZS2058.

  2021cites this paper
• Evidence from comparative genomic analyses indicating that Lactobacillus-mediated irritable bowel syndrome alleviation is mediated by conjugated linoleic acid synthesis.

  2021cites this paper
• Diosgenin and 4-Hydroxyisoleucine from Fenugreek Are Regulators of Genes Involved in Lipid Metabolism in The Human Colorectal Cancer Cell Line SW480

  2020cites this paper
• Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseases

  2020cites this paper
• Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation

  2020cites this paper
• Conjugated Linoleic Acid Effects on Cancer, Obesity, and Atherosclerosis: A Review of Pre-Clinical and Human Trials with Current Perspectives

  2019cites this paper
• Dietary conjugated linoleic acid modulates morphology, selective immune parameters, and gene expressions in the intestine of grass carp

  2019cites this paper
• Nutritional approach as therapeutic manipulation in inflammatory bowel disease

  2019cites this paper
• Orally Administered CLA Ameliorates DSS-induced Colitis in Mice via Intestinal Barrier Improvement, Oxidative Stress Reduction, Inflammatory Cytokine and Gut Microbiota Modulation.

  2019cites this paper
• Consumption of conjugated linoleic acid (CLA)-supplemented diet during colitis development ameliorates gut inflammation without causing steatosis in mice.

  2018cites this paper
• Conjugated linoleic acid prevents damage caused by intestinal mucositis induced by 5-fluorouracil in an experimental model.

  2018cites this paper
• Effect of Conjugated Linoleic Acid-enriched Butter After 24 hours of Intestinal Mucositis Induction

  2017cites this paper
• Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.

  2017cites this paper
• Protective effect of Rumenic acid rich cow's milk against colitis is associated with the activation of Nrf2 pathway in a murine model.

  2017cites this paper
• Dietary n‑3 polyunsaturated fatty acids ameliorate Crohn's disease in rats by modulating the expression of PPAR‑γ/NFAT.

  2017cites this paper
• Short chain and polyunsaturated fatty acids in host gut health and foodborne bacterial pathogen inhibition

  2017cites this paper
• SMJEŠTAJ TFF1 I TFF3 PROTEINA U RAZLIČITIM STADIJIMA RAZVOJA MIŠJEG ZAMETKA

  2017cites this paper
• Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice

  2016cites this paper
• Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice

  2016cites this paper
• Conjugated linoleic acid and nitrite attenuate mitochondrial dysfunction during myocardial ischemia.

  2016cites this paper
• Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease.

  2015cites this paper
• Co-treatment with conjugated linoleic acid and nitrite modulates mitochondrial respiration and electron transport chain activity in vivo and attenuates mitochondrial dysfunction during cardiac injury.

  2015cites this paper
• The role of immunomodulators on intestinal barrier homeostasis in experimental models.

  2015cites this paper
• Review of the roles of conjugated linoleic acid in health and disease

  2015cites this paper
• Trefoil factors in inflammatory bowel disease.

  2014cites this paper
• The Microbiome, PPARγ and AhR in the inflammation- metabolism interface within the gastrointestinal tract

  2014cites this paper
• THE ROLE OF NITRATE AND CONJUGATED LINOLEIC ACID

  2014cites this paper
• The Microbiome, PPARγ and AhR in the inflammation-metabolism interface within the gastrointestinal tract

  2014cites this paper
• Kinetic Characterization of an Intestinal Trefoil Factor Receptor

  2013cites this paper
• Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease

  2013cites this paper